Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06152029 · ClinicalTrials.gov registry record
Temporary Peripheral Nerve Stimulation System for Osteoarthritis of the Knee
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 12
- Enrollment target
NCT06152029: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT06152029 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06152029 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the treatment outcomes of patients with chronic knee pain secondary to osteoarthritis that have received a temporary peripheral nerve stimulation system.
Interventions
- DEVICE Temporary PNS system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2025-10-20 |
Why NCT06152029 stopped before completion
NCT06152029 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Temporary PNS system is the first listed.
NCT06152029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06152029 about?
NCT06152029 is a clinical study titled "Temporary Peripheral Nerve Stimulation System for Osteoarthritis of the Knee". The purpose of this study is to demonstrate the treatment outcomes of patients with chronic knee pain secondary to osteoarthritis that have received a temporary peripheral nerve stimulation system.
What is the current status of trial NCT06152029?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2023-11-15. Estimated completion is 2025-10-20.
What interventions are being tested in trial NCT06152029?
The interventions under investigation include: Temporary PNS system (DEVICE).
Who is sponsoring clinical trial NCT06152029?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI